Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-ESHAP and Autologous Transplantation in Refractory/Relapsed DLBCL
NCT01278602Phase 2Unknown
- Sponsor
- Fudan University
- Start
- Dec 2010
- Primary completion
- Dec 2013
- Modality
- Nanoparticles, Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab, etoposide, Cisplatin micelle injection (HA132), cytarabine, methylprednisolone injection in diffuse large B-cell lymphoma (DLBCL), sponsored by Fudan University. Status: unknown.
02
Drugs
rituximabetoposideCisplatin micelle injection (HA132)cytarabinemethylprednisolone injection
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT01278602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01278602.